Ina Schim van der Loeff

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Single-cell multi-omics analysis of the immune response in COVID-19

Emily Stephenson, Gary Reynolds, Rachel A. Botting et al. · Nature Medicine · 2021 · 793 citations · Full text

COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study

Jessica Manson, Colin Crooks, Meena Naja et al. · The Lancet Rheumatology · 2020 · 266 citations · Full text

Patient Care, Epidemiological Trend, Covid-19 Pandemic +6

National Early Warning Score 2 (NEWS2) to identify inpatient COVID-19 deterioration: a retrospective analysis

Kenneth F. Baker, Aidan T. Hanrath, Ina Schim van der Loeff et al. · Clinical Medicine · 2021 · 98 citations · Full text